Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Next-Gen Video Service Unveiled at INTX | Jaison Dolvane - Founder & CEO of Espial Group Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jaison Dolvane. President/CEO/Co-Founder, Espial Group Inc
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
P3 Water Summit: Partner Allan Marks on Private Sector Opportunities | Allan Marks - Partner of Milbank LLP
00:10:00
Unveiling the Truth Behind the Perceived Water Crisis in Agriculture | Luca Fabbri, CEO, Farmland Partners Inc.
00:10:00
Keys to Successful IIoT Rollouts: Culture, Champions, and Systems
00:10:00
Driving Regional Growth: Insights from Sheikh Ali Alwaleed Al Thani of Invest Qatar | Sheikh Ali Alwaleed Al Thani - CEO, Investment Promotion Agency Qatar
00:10:00
Why Startups Innovate Faster than Internet Giants|Hurst lin,General Partner, DCM
00:10:00
Interactive Session with Aleksander Caban: Carbon Studio's Path to VR Innovation | Aleksander Caban, a board member , Carbon Studio SA.
00:10:00
Building a Global Investment Powerhouse: Stephen Schwarzman on Leading Blackstone | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
2019 Investing Opportunities in Fixed Income | Rick Genoni and Ellen Cammer Discuss Strategies
00:10:00
Saudi Minister Discusses Supply Chain Investments at FII Conference | Bandar Alkhorayef - Minister of Industry and Mineral Resources
00:10:00
Mirage Echo: Pioneering Coal Development in Investor-Friendly Botswana
00:10:00
Achieving Financial Independence with Chris Mamula | Chris Mamula - Financial Planner at Abundo Wealth
00:10:00
Corporate Venture Capital and its Benefits|Bart Emery,Corporate Venture Capital Manager,Inflect Health